What is contract validation?
In the pharmaceutical and life sciences industry, contract validation refers to the systematic review and verification of payer and channel contracts against actual claims, formulary, and utilization data to ensure contractual terms are being applied correctly.
This typically includes validating the following to ensure that what was negotiated in the contract is actually taking place:
- Formulary placement and access status
- Rebate eligibility and payment accuracy
- Market share or utilization thresholds
- Compliance with value-based or outcomes-based agreements
- Alignment across payer, PBM, and health plan implementations
What does the contract validation process involve?
While approaches vary by organization, effective contract validation typically includes several core steps:
Contract Term Review: Key contractual terms—such as rebate structure, access requirements, and performance metrics—are standardized and mapped to measurable data elements.
Data Alignment and Integration: Claims, formulary, and enrollment data are aligned to contract terms to ensure accurate comparison between expected and actual performance.
Performance Verification: Manufacturers assess whether access, utilization, and financial outcomes align with contractual commitments across payers and channels.
Discrepancy Identification: Any misalignment, such as incorrect formulary placement, unexpected utilization patterns, or rebate miscalculations, is flagged for further review.
Resolution and Optimization: Findings inform corrective actions, payer discussions, and future contracting strategies.
Why is contract validation critical for pharma companies?
Modern payer contracts often include multiple tiers, carve-outs, performance guarantees, and product portfolios. As contracting strategies evolve, so do the risks.
Without robust contract validation, manufacturers may unknowingly accept inaccuracies that impact both short-term revenue and long-term access strategy. Errors in contract execution can lead to overpaid rebates, missed rebate opportunities, or incorrect pricing.
Identifying discrepancies early allows manufacturers to proactively address issues with payers, rather than reacting after financial or access impacts have already occurred.
Contract validation also helps manufacturers maintain documentation and defensible data trails to support audits and compliance requirements.
What is the role of data in contract validation?
Contract validation depends on timely, accurate, and integrated data. With fragmented payer systems and frequent formulary changes, technology-enabled validation is essential. For organizations managing hundreds of payer contracts, scalable technology is the only sustainable approach. Advanced analytics platforms can help manufacturers:
- Monitor contract performance in near real time
- Identify payer-level discrepancies faster
- Link contract terms to real-world access and utilization data
- Reduce reliance on manual audits and spreadsheets
Does contract validation help manufacturers improve their market access strategy?
Beyond risk mitigation, contract validation can provide manufacturers with unique insights into payer behavior. By understanding how contracts perform in practice, manufacturers can:
- Refine future contracting strategies
- Identify payers that consistently underperform or misapply terms
- Align contracting decisions with real-world access outcomes
- Support evidence-based discussions with internal and external stakeholders
Manufacturers that invest in validating their contracts gain clearer visibility into access performance, stronger financial control, and greater confidence in their market access strategy.
